DSpace Repository

Enzyme-Driven Switchable Fluorescence-SERS Diagnostic Nanococktail for the Multiplex Detection of Lung Cancer Biomarkers

Show simple item record

dc.contributor.author Saranya, G
dc.contributor.author Joseph, M M
dc.contributor.author Karunakaran, V
dc.contributor.author Nair, J B
dc.contributor.author Saritha, V N
dc.contributor.author Veena, V S
dc.contributor.author Sujathan, K
dc.contributor.author Ajayaghosh, A
dc.contributor.author Maiti, K K
dc.date.accessioned 2019-07-09T09:22:09Z
dc.date.available 2019-07-09T09:22:09Z
dc.date.issued 2018-10-24
dc.identifier.citation Applied Materials and Interfaces; 10 (45):38807–38818 en_US
dc.identifier.uri https://pubs.acs.org/doi/10.1021/acsami.8b15583
dc.identifier.uri http://10.10.100.66:8080/xmlui/handle/123456789/3397
dc.description.abstract Comprehensive profiling of multiple protein targets plays a critical role in deeper understanding of specific disease conditions associated with high heterogeneity and complexity. Herein, we present the design and fabrication of smart programmable nanoarchitectures, which could integrate clinically relevant diagnostic modalities for the multiplexed detection of most prevalent panel of disease biomarkers present in lung cancer. The multiplex nanoprobes were prepared by attaching dual-functional Raman-active fluorogens onto spherical gold nanoparticles through a peptide linker, Phe-Lys-Cys (FKC), which is engineered with a cathepsin B (cathB) enzyme cleavage site. The presence of cathB induces the scission of FKC upon homing into the cancer cells, resulting in the release of the initially latent fluorophores with a concomitant quenching of the surface-enhanced Raman signal intensity, thereby realizing an on−off switching between the fluorescence and Raman modalities. The enzyme-triggered switchable nanoprobes were utilized for the simultaneous detection of pathologically relevant lung cancer targets by tethering with specific antibody units. The multiplex-targeted multicolor coded detection capability of the antitags was successfully developed as a valid protein screening methodology, which can address the unmet challenges in the conventional clinical scenario for the precise and early diagnosis of lung cancer. en_US
dc.language.iso en en_US
dc.publisher American Chemical Society en_US
dc.subject fluorescence en_US
dc.subject SERS en_US
dc.subject antitag en_US
dc.subject multiplex en_US
dc.subject cocktail en_US
dc.subject lung cancer en_US
dc.title Enzyme-Driven Switchable Fluorescence-SERS Diagnostic Nanococktail for the Multiplex Detection of Lung Cancer Biomarkers en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

  • 2018
    Journal Articles authored by NIIST researchers published in 2018

Show simple item record

Search DSpace


Advanced Search

Browse

My Account